193 related articles for article (PubMed ID: 35804404)
1. Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.
Marchand A; Caille A; Gissot V; Giraudeau B; Lengelle C; Bourgoin H; Largeau B; Leducq S; Maruani A
Trials; 2022 Jul; 23(1):557. PubMed ID: 35804404
[TBL] [Abstract][Full Text] [Related]
2. Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial.
Leducq S; Caille A; Barbarot S; Bénéton N; Bessis D; Boccara O; Bursztejn AC; Chiaverini C; Dompmartin A; Droitcourt C; Gissot V; Goga D; Guibaud L; Herbreteau D; Le Touze A; Léauté-Labrèze C; Lorette G; Mallet S; Martin L; Mazereeuw-Hautier J; Phan A; Plantin P; Quéré I; Vabres P; Bourgoin H; Giraudeau B; Maruani A;
Trials; 2019 Dec; 20(1):739. PubMed ID: 31847908
[TBL] [Abstract][Full Text] [Related]
3. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Topical Sirolimus (Rapamycin) for the Treatment of Microcystic Lymphatic Malformations.
Ivars M; Redondo P
JAMA Dermatol; 2017 Jan; 153(1):103-105. PubMed ID: 27784048
[No Abstract] [Full Text] [Related]
6. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
7. Topical Tacrolimus 0.1% for treatment of cutaneous microcystic lymphatic malformations.
Salvia SA; Amore MA; Papendieck CM
Lymphology; 2021; 54(2):106-111. PubMed ID: 34735755
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
Ozeki M; Asada R; Saito AM; Hashimoto H; Fujimura T; Kuroda T; Ueno S; Watanabe S; Nosaka S; Miyasaka M; Umezawa A; Matsuoka K; Maekawa T; Yamada Y; Fujino A; Hirakawa S; Furukawa T; Tajiri T; Kinoshita Y; Souzaki R; Fukao T
Regen Ther; 2019 Jun; 10():84-91. PubMed ID: 30705924
[TBL] [Abstract][Full Text] [Related]
9. Use of topical rapamycin in the treatment of superficial lymphatic malformations.
García-Montero P; Del Boz J; Baselga-Torres E; Azaña-Defez JM; Alcaraz-Vera M; Tercedor-Sánchez J; Noguera-Morel L; Vera-Casaño Á
J Am Acad Dermatol; 2019 Feb; 80(2):508-515. PubMed ID: 30296533
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Lymphatic Malformations with the mTOR Inhibitor Sirolimus: A Systematic Review.
Wiegand S; Wichmann G; Dietz A
Lymphat Res Biol; 2018 Aug; 16(4):330-339. PubMed ID: 29924669
[TBL] [Abstract][Full Text] [Related]
11. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
Wiegand S; Dietz A; Wichmann G
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus in the Treatment of Microcystic Lymphatic Malformations: A Systematic Review.
Teng JMC; Hammill A; Martini J; Treat J
Lymphat Res Biol; 2023 Apr; 21(2):101-110. PubMed ID: 35852876
[No Abstract] [Full Text] [Related]
14. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.
Koenig MK; Bell CS; Hebert AA; Roberson J; Samuels JA; Slopis JM; Tate P; Northrup H;
JAMA Dermatol; 2018 Jul; 154(7):773-780. PubMed ID: 29800048
[TBL] [Abstract][Full Text] [Related]
15. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
16. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
[No Abstract] [Full Text] [Related]
17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
18. Topical rapamycin and microcystic lymphatic malformations.
Gu Y; Sebaratnam DF
J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
[No Abstract] [Full Text] [Related]
19. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
[TBL] [Abstract][Full Text] [Related]
20. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]